IMUGENE LIMITED - Charts / Financials

0.00%

1.5¢

Market Cap $112.0M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. WEBINAR: What investors should know about what it takes for ASX-listed companies to get medical developments...

REFRESH

Day
Open	1.5¢		Day High	1.6¢		Day Low	1.4¢
Daily Volume	8369714

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
76	1.4¢	17029463		3	1.5¢	1061875

Directors & Senior Management

Mr. Paul E. Hopper	Executive Chairman of the Board
Ms. Leslie Chong	Chief Executive Officer, Managing Director, Executive Director
Mr. Darren Keamy	Chief Financial Officer, Company Secretary
Dr. Bradley Glover	Chief Operating Officer
Dr. Monil Shah	Chief Business Officer
Dr. Paul Woodard	Chief Medical Officer
Ms. Kimberlee Cobleigh Drapkin	Non-Executive Independent Director
Dr. Jakob Dupont	Non-Executive Independent Director
Dr. Lesley Russell	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.5¢		Change 0.000(0.00%)		Mkt cap ! $112.0M

Open	High	Low	Value	Volume
1.5¢	1.6¢	1.4¢	$125.4K	8.369M

Buyers (Bids)

No.	Vol.	Price($)
76	17029463	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	1061875	3

View Market Depth

No.	Vol.	Price($)
67	15122749	0.014
35	10959455	0.013
40	8162244	0.012
13	3263001	0.011
30	6569728	0.010

Price($)	Vol.	No.
0.015	873992	2
0.016	10695661	30
0.017	6170154	16
0.018	6533023	29
0.019	6839697	18

Last trade - 16.10pm 13/06/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories